# Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-2) Trial - THE CHART-2 TRIAL

> **NCT02317458** · PHASE3 · UNKNOWN · sponsor: **Celyad Oncology SA** · enrollment: 400 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **BIOLOGICAL:** Experimental
- **BIOLOGICAL:** Sham comparator

## Key facts

- **NCT ID:** NCT02317458
- **Lead sponsor:** Celyad Oncology SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06
- **Primary completion:** 2020-03
- **Final completion:** —
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2016-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02317458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02317458, "Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-2) Trial - THE CHART-2 TRIAL". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02317458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*